Clinical Trials Directory

Trials / Terminated

TerminatedNCT01906229

Lung and Systemic Inflammation in the Critically Ill Patient

Acute Pulmonary and Systemic Inflammation in Mechanically Ventilated Intensive Care Patients

Status
Terminated
Phase
Study type
Observational
Enrollment
8 (actual)
Sponsor
Rigshospitalet, Denmark · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Acute respiratory distress syndrome (ARDS) is a devastating form of acute lung inflammation, that may be caused by a variety of insults with pulmonary and systemic infectious disease being the most common predisposing factor. Sepsis, on the other hand, represents the systemic inflammatory response to an invading pathogen, which may inflict damage upon the host through organ dysfunction. ARDS and sepsis are heterogenous clinical conditions that have a high mortality, and both diseases involve a complex interplay of different inflammatory mediators and cell types. It has been suggested that locally released inflammatory mediators pass from the lungs into the bloodstream following ARDS, triggering systemic inflammation. Conversely, it is possible that severe systemic inflammation may lead to ARDS by an influx of inflammatory mediators from the bloodstream to the lungs. However, the time course and the possible pathways for this transmission of disease have yet to be established. Investigators hypothesize that: 1. Primary systemic inflammation is followed by a secondary pulmonary inflammatory response 2. Primary pulmonary inflammation is followed by a secondary systemic inflammatory response 3. Both primary and secondary inflammatory responses are characterized by the appearance of pro-inflammatory cytokines, inflammatory cells and production of collagen-like proteins (termed 'lectins') 4. The inflammatory response is most pronounced in the primary afflicted compartment.

Conditions

Timeline

Start date
2013-07-01
Primary completion
2018-12-01
Completion
2018-12-01
First posted
2013-07-24
Last updated
2018-12-11

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01906229. Inclusion in this directory is not an endorsement.